Currently, there is a strong focus on HSFs as potential therapeutic targets, partly due to their regulatory role in transcription of HSP-encoding genes but also due to a multitude of newly discovered cancer-specific HSF target genes. The gene discussed is HSP90B2P; the disease is cancer.